Skip to content

Dependence of LV Hemodynamics on Pacing Site

Characterization of LV Hemodynamics During Epicardial and Endocardial Pacing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01564173
Enrollment
13
Registered
2012-03-27
Start date
2012-06-30
Completion date
2016-03-31
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to evaluate the effects of epicardial and endocardial pacing at each side of the left ventricular (LV) segments on cardiac hemodynamics in patients with impaired LV function undergoing epicardial ablation and mapping procedure. Hemodynamic function will be assessed during a pacing protocol with a pressure catheter inserted in the LV.

Interventions

None listed

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is already indicated for epicardial mapping and ablation of arrhythmia(s) utilizing a transcutaneous subxiphoid approach * Be in sinus rhythm * Have LVEF \< 40% * Have the ability to provide informed consent for study participation and be willing and able to comply with the CIP (Clinical Investigational Plan) described evaluations

Exclusion criteria

* Have permanent AF * Have pericardial disease * Have a recent myocardial infarction within 40 days prior to enrollment * Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures * Have had a recent CVA or TIA within 3 months prior to enrollment * Be less than 18 years of age * Be pregnant

Design outcomes

Primary

MeasureTime frameDescription
Invasive Dp/dt MaxAcute E.P. ProcedureVariation on invasive Dp/dt max during dedicated pacing site

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026